Acupoint herbal patching for postherpetic neuralgia: A systematic review and meta-analysis

Bingyu Pu, Jian Wang, Xiaoxue Lu, Peilin Yu, Chengjie Wang, Juan Li2022 · DOI

Abstract

Postherpetic neuralgia (PHN) is a common and debilitating complication of herpes zoster (HZ), characterized by persistent pain that significantly impacts patient quality of life and creates a substantial economic burden. This paper presents a formal protocol for a systematic review and meta-analysis designed to evaluate the efficacy and safety of acupoint herbal patching—a Traditional Chinese Medicine (TCM) intervention—compared to standard clinical treatments. By synthesizing data from randomized controlled trials (RCTs), this study aims to establish a rigorous evidence base for this intervention.

Background and Problem Statement

Postherpetic neuralgia is defined as pain persisting for more than one month after the healing of a herpes zoster rash. The incidence of HZ is approximately 3 to 5 per 1,000 person-years, and the risk of developing PHN among outpatients varies between 5% and 30%. Beyond physical pain, PHN severely affects mood, sleep, and mental health, often leading to anxiety and depression.

Acupoint herbal patching is a therapeutic method guided by TCM theory, involving the application of medicinal patches to specific acupuncture points to stimulate the skin and meridians. While widely used in clinical practice, its effectiveness relative to Western pharmacological or physical therapies remains a subject of debate. There is a clear need for a high-quality, systematic synthesis of existing clinical data to determine if this method is a viable, safe, and effective alternative or adjunct to current treatments.

Methodology

This study follows a rigorous protocol to ensure the synthesis of high-quality evidence.

Search Strategy

The research team will perform a comprehensive search of eight major medical databases. English-language sources include MEDLINE, Embase, the Cochrane Library, and Web of Science. Chinese-language sources include the China National Knowledge Infrastructure (CNKI), Wan-Fang Database, China Biomedical Literature Service System (CBM), and Chongqing VIP Chinese Science.

Inclusion and Exclusion Criteria

The review will exclusively include Randomized Controlled Trials (RCTs) to maintain the highest standard of evidence. The experimental group must receive acupoint herbal patching, either as a standalone treatment or in combination with other therapies. The control group must receive standard clinical treatments, excluding the use of herbal patches.

Quality Assessment and Data Synthesis

To minimize bias, two independent researchers will evaluate the included studies using the Cochrane risk of bias tool, covering domains such as allocation concealment and blinding. A third researcher will act as an arbitrator in case of disagreements.

Statistical analysis will be conducted using Review Manager 5.2 and Stata 16.0:

  • Outcome Measures: Risk ratios (RR) will be used for dichotomous outcomes, while mean differences (MD) or standardized mean differences (SMD) will be used for continuous outcomes, such as pain scores.
  • Heterogeneity Analysis: The $I^2$ statistic will measure inconsistency across studies. If $I^2 \ge 50\%$, the team will perform subgroup or sensitivity analyses to identify the source of variance, such as differences in treatment duration or patient demographics.
  • Publication Bias: Funnel plots and Egger tests will be employed to detect potential publication bias.

Expected Results and Significance

As this is a protocol, final results are pending. However, the authors have pre-defined primary outcomes to ensure a multidimensional evaluation:

  1. Effectiveness: Changes in pain scores (e.g., Visual Analogue Scale).
  2. Safety: Incidence and severity of adverse reactions to provide a full risk-benefit profile.
  3. Secondary Data: Analysis of disease course and intervention specifics.

This protocol represents a significant effort to apply Western "gold standard" statistical rigor to Traditional Chinese Medicine practices. By bridging these traditions, the resulting review will provide a foundation for larger-scale, multi-center clinical trials and serve as a clinical guideline for practitioners.

Limitations

The authors acknowledge several constraints, including the exclusion of non-RCT data which might miss long-term observational evidence. Additionally, the search is limited to English and Chinese languages, potentially omitting relevant studies published in other languages.

Summary updated

Abstract

Review question / Objective: The efficacy and safety of Acupoint herbal patching in patients with postherpetic neuralgia which compare with other treatment methods.Condition being studied: Postherpetic neuralgia (PHN), a pain lasting more than 1 month after healing of herpes zoster (HZ) rash, is a common complication of HZ.The incidence of HZ is about 3 ~ 5 / 1000 person-years, and the risk of PHN varies from 5 % to 30 % in outpatients with HZ.PHN affects mood , sleep, anxiety and depression of patient, and leads to greater e c o n o m i c b u rd e n .A c u p o i n t h e r b a l patching is a method guided by the theory INPLASY 1 International Platform of Registered Systematic Review and Meta-analysis Protocols INPLASY PROTOCOL Acupoint herbal patching for postherpetic neuralgia: A systematic review and meta-analysis
BibTeX
@misc{pu2022acupoint,
  author = {Bingyu Pu and Jian Wang and Xiaoxue Lu and Peilin Yu and Chengjie Wang and Juan Li},
  title = {{Acupoint herbal patching for postherpetic neuralgia: A systematic review and meta-analysis}},
  year = {2022},
  doi = {10.37766/inplasy2022.7.0007},
}
Figure